This is a good, solvent company going through a lot of changes. Almost time to buy. The Street showing 42% Buy rating; 32% Hold rating and a 26% Sell rating. Revenue is up, but it hasn't trickled down to the bottom line yet. Insider buying from the entire senior management is a good sign. I think there might be another 10% downside. Looking to buy at $35. Wish the dividend was a little better. If they can improve the cash flow and up the dividend, this will be a no brainier.
News 
Market Data 
Discover 
